To elucidate the regulation of the nitric oxide (NO) and carbon monoxide (CO) pathways in preeclampsia and to evaluate the ratio of asymmetric dimethylarginine (ADMA) to symmetric dimethylarginine (SDMA) as a marker for preeclampsia.
Methods:
Maternal plasma and placental samples were obtained from 20 participants with preeclampsia and 23 controls. Enzyme-linked immunosorbent assay was used to measure plasma NO, ADMA, and SDMA as well as placental NO and hemeoxygnase 1 (HO-1). Western blot was used to measure placental dimethylarginine dimethylaminotransferases (DDAH-I and DDAH-II).
Results:
Placental DDAH-I, placental DDAH-II, placental NO, and placental HO-1 were significantly decreased in participants with preeclampsia. While ADMA and SDMA levels were decreased in preeclampsia, the ADMA-SDMA ratio was not significantly different.
Conclusions:
Decreased DDAH and HO with preeclampsia suggest that they are important points in the regulatory pathways of NO and CO production that are altered in preeclampsia. The ADMA-SDMA ratio is not a useful test for preeclampsia.
SibaiBM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181–192.
2.
MervielPCarbillonLChallierJCRabreauMBeaufilsMUzanS. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol. 2004;115(2):134–147.
3.
BogerRHDiemertASchwedhelmELuneburgNMaasRHecherK. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. Gynecol Obstet Invest. 2010;69(1):1–13.
4.
BainbridgeSASmithGN. HO in pregnancy. Free Radic Biol Med. 2005;38(8):979–988.
5.
FicklingSAWilliamsDVallancePNusseySSWhitleyGS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet. 1993;342(8865):242–243.
6.
HoldenDPFicklingSAWhitleyGSNusseySS.Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1998;178(3):551–556.
7.
SpeerPDPowersRWFrankMPHargerGMarkovicNRobertsJM.Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. Am J Obstet Gynecol. 2008;198(1):112.e1–112.e7.
8.
PetterssonAHednerTMilsomI.Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand. 1998;77(8):808–813.
9.
EllisJWennerholmUBBengtssonALevels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand. 2001;80(7):602–608.
10.
BraekkeKUelandPMHarsemNKStaffAC. Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. Pediatr Res2009;66(4):411–415.
11.
MaoDCheJLiKAssociation of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet. 2010;282(4):371–375.
12.
MaasRBogerRHSchwedhelmEPlasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. JAMA. 2004;291(7):823–824.
13.
SiroenMPTeerlinkTBolteACNo compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia. Gynecol Obstet Invest2006;62(1):7–13.
14.
KingRGDi IulioJLGudeNMBrenneckeSP. Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae. Reprod Fertil Dev1995;7(6):1581–1584.
15.
PopeAJKaruppiahKCardounelAJ. Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res. 2009;60(6):461–465.
16.
AhmedARahmanMZhangXInduction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med. 2000;6(5):391–409.
17.
BarberARobsonSCMyattLBulmerJNLyallF. Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J. 2001;15(7):1158–1168.
18.
BrownMALindheimerMDde SwietMVan AsscheAMoutquinJM.The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1): IX–XIV.
19.
LiaoWXMagnessRRChenDB. Expression of estrogen receptors-alpha and -beta in the pregnant ovine uterine artery endothelial cells in vivo and in vitro. Biol Reprod. 2005;72(3):530–537.
20.
McLaughlinBELashGESmithGNHeme Oxygenase Expression in Selected Regions of Term Human Placenta. Exp Biol Med. 2003;228(5):564–567.
21.
AkbarFHeinonenSPirskanenMUimariPTuomainenTPSalonenJT. Haplotypic association of DDAH1 with susceptibility to pre-eclampsia. Mol Hum Reprod. 2005;11(1):73–77.
22.
Vadillo-OrtegaFPerichart-PereraOEspinoSEffect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 2011;342: d2901.
23.
RytlewskiKOlszaneckiRKorbutRZdebskiZ. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest. 2005;35(1):32–37.
